Shares of Ariad Pharmaceuticals soared 73% and had its best trading day in 17 years on Monday. Why the big explosion? The company announced that it is being bought out by Japanese pharmaceutical company Takeda Pharmaceuticals. In the agreement, Takeda will buy Ariad for $24 a share, or about $5.2 billion. The boards of both … Continue reading “Ariad Pharmaceuticals (ARIA) Shares Explode After Takeover News”
Biotech & Pharma
Biotech & Pharma
This Vitamin Deficiency Is Linked To Autism
What causes autism has been a question that many people disagree over. A new theory…
December 15, 2016
Biotech & Pharma
Valeant (VRX) Shares Got Crushed After Huge Talks With Japan Fall Apart
Valeant Pharmaceuticals shares fell almost 8% on Wednesday after news surfaced that the company's talks…
November 30, 2016
Biotech & Pharma
GlaxoSmithKline (GSK) Filed To Get U.S. Approval For Triple Lung Drug
GlaxoSmithKline, tha largest drugmaker in Britain, announced on Monday that the company as filed its…
November 21, 2016
Biotech & Pharma
Pfizer (PFE) Just Ditched Its High-Profile Cholesterol Drug
Shares of Pfizer dropped about 2% after the pharma giant decided to scrap its high-profile…
November 1, 2016
Biotech & Pharma
A Bernie Sanders Tweet Sent Ariad (ARIA) Shares Tumbling
Ariad Pharmaceuticals has soared over 90% this year, but shares fell 14.8% after Bernie Sanders…
October 14, 2016
Biotech & Pharma
Positive Lung Cancer Trial Results Send Merck (MRK) Shares Higher
Merck's Keytruda lung cancer drug just produced successful results in a Phase II/III trial, and…
October 10, 2016
Biotech & Pharma
EpiPen Maker Mylan Has Been Abusing Our Tax Money
It has been a story that has had many people sitting in utter disgust. EpiPen…
October 6, 2016
Biotech & Pharma
Could This Cancer Drug Help Alzheimer’s Patients?
The Alzheimer's Drug Discovery Foundation (ADDF) has just awarded a $2.1 million grant to R.…
September 29, 2016
Biotech & Pharma
Allergan (AGN) May Pay A Lot Of Money For This Company
Pharmaeutical titan, Allergan, is acquiring Tobira Therapuetics in a deal that's initially for $28.35 per…
September 20, 2016
Biotech & Pharma
New Cancer Drug Gives Hope To Many
A small trial has given hope to cancer fighters, especially those with the deadly form…
September 8, 2016
Biotech & Pharma
Merck & Co.(MRK) Just Discontinued This Major Pipeline Drug
Merck & Co. Inc. made a big announcement over its osteoporosis pipeline drug, odanacatib. The…
September 5, 2016
Biotech & Pharma
Mylan (MYL) To Make Cheaper Version Of EpiPen
It seems like Mylan NV has been paying attention to all the backlash against it…
August 29, 2016
Biotech & Pharma
Mylan’s (MYL) Price Of Epi Pens Just Got Cut In Half
EpiPens cost a lot of money but Mylan Pharamceuticals, the company who manufactures them, just…
August 25, 2016